 |
|
A Population-Based Case-Cohort Study of Drug-Associated Agranulocytosis
Melanie M. van der Klauw, MD, PhD;
Robert Goudsmit, MD, PhD;
M. Ruud Halie, MD, PhD;
Mars B. van't Veer, MD, PhD;
Ron M. C. Herings, PharmD, PhD;
J. H. Paul Wilson, MD;
Bruno H. Ch. Stricker, MB, PhD
Arch Intern Med. 1999;159:369-374.
Background Agranulocytosis is a life-threatening disorder, often caused by drugs. Incidences or risks of drug-induced agranulocytosis are not well known, since it is rare.
Methods To determine the risk of drug-associated agranulocytosis as a reason for admission to Dutch hospitals, we performed a population-based case-cohort study. Hospital discharge data came from the Dutch Centre for Health Care Information, Utrecht, which contains data on all general and university hospitals in the Netherlands. The reference cohort consisted of all persons in the catchment area of the Pharmaco Morbidity Record Linkage System (PHARMO RLS) in the Netherlands, composing a population of approximately 220,000 to 484,000 persons from 1987 through 1990. All admissions during that period with agranulocytosis or related diagnoses were included in the study (n=923). The potential causes of agranulocytosis were assessed in all cases classified as probable or possible agranulocytosis.
Results Discharge summaries were received of 753 admissions, of which 678 contained enough information for analysis. Of the 678, 108 were classified as "agranulocytosis probable" or as "agranulocytosis possible." In 75 of these 108 cases, agranulocytosis had been the reason for admission. Fifteen patients had used methimazole within 10 days before developing agranulocytosis; 2, carbimazole; 9, sulfasalazine; 8, sulfamethoxazole-trimethoprim; 4, clomipramine hydrochloride; and 2, dipyrone with analgesics, yielding adjusted relative risks of agranulocytosis of 114.8 (for thyroid inhibitors combined) (95% confidence interval [CI], 60.5-218.6), 74.6 (95% CI, 36.3-167.8), 25.1 (95% CI, 11.2-55.0), 20.0 (95% CI, 6.1-57.6), and 26.4 (95% CI, 4.4-11.1), respectively.
Conclusions The highest relative risks were found for thyroid inhibitors, sulfamethoxazole-trimethoprim, sulfasalazine, clomipramine, and dipyrone combined with analgesics.
From the Departments of Internal Medicine II (Drs van der Klauw and Wilson) and Epidemiology and Biostatistics (Dr Stricker), Erasmus University Medical School, Rotterdam; Drug Safety Unit, Inspectorate for Health Care, Rijswijk, Amsterdam (Drs van der Klauw and Stricker); Department of Hematology, University Hospital Groningen, Groningen (Dr Halie); Department of Hematology, Dr Daniel den Hoed Cancer Centre, Rotterdam (Dr van't Veer); and Department of Pharmacoepidemiology and Pharmacotherapy, University of Utrecht, Utrecht (Dr Herings), the Netherlands. Dr Goudsmit is in private practice in Amsterdam.
RELATED LETTERS
Drug-Associated Agranulocytosis: Experience at Strasbourg Teaching Hospital
Andrès Emmanuel and Frédéric Maloisel
Arch Intern Med. 1999;159(19):2366-2367.
EXTRACT
| FULL TEXT
Drug-Induced Allergic Cytopenia: In Vitro Confirmation by the Lymphocyte Transformation Test
Bernhardt Sachs, Stephan Erdmann, Iris Borchardt, Peter Drüke, Hans Friedrich Merk, and Jan Palmblad
Arch Intern Med. 2000;160(14):2218-2219.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Agranulocytosis Induced by Nonchemotherapy Drugs
Andersohn et al.
ANN INTERN MED 2008;148:320-321.
FULL TEXT
Systematic Review: Agranulocytosis Induced by Nonchemotherapy Drugs
Andersohn et al.
ANN INTERN MED 2007;146:657-665.
ABSTRACT
| FULL TEXT
Myeloid disorders
Link and Wun
ASH-SAP 2007;2007:143-171.
FULL TEXT
Population-Based Drug-Induced Agranulocytosis
Ibanez et al.
Arch Intern Med 2005;165:869-874.
ABSTRACT
| FULL TEXT
Congenital and Acquired Neutropenia
Berliner et al.
ASH Education Book 2004;2004:63-79.
ABSTRACT
| FULL TEXT
Prednisone-induced neutropenia after cadaveric kidney transplantation
Schaub et al.
Nephrol Dial Transplant 2002;17:1119-1121.
FULL TEXT
Antibiotic-Induced Agranulocytosis: A Monocentric Study of 21 Cases
Andres and Maloisel
Arch Intern Med 2001;161:2619-2619.
FULL TEXT
Haematopoietic growth factor in antithyroid-drug-induced agranulocytosis
Andres et al.
QJM 2001;94:423-428.
ABSTRACT
| FULL TEXT
Cyclosporin for sulphasalazine-induced aplastic anaemia in a patient with early rheumatoid arthritis
Nurmohamed et al.
Rheumatology (Oxford) 2000;39:1431-1433.
FULL TEXT
Drug-Induced Allergic Cytopenia: In Vitro Confirmation by the Lymphocyte Transformation Test
Sachs et al.
Arch Intern Med 2000;160:2218-2219.
FULL TEXT
Drug-Induced Neutropenias: Now and Then
Palmblad et al.
Arch Intern Med 1999;159:2745-2745.
FULL TEXT
Drug-Associated Agranulocytosis: Experience at Strasbourg Teaching Hospital
Emmanuel and Maloisel
Arch Intern Med 1999;159:2366-2367.
FULL TEXT
|
